These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 699677)

  • 21. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
    Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
    J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disk diffusion susceptibility testing of dermatophytes with imidazoles.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1995 Oct; 38(4):369-74. PubMed ID: 9726146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    González GM
    Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
    Corrado ML; Weitzman I; Stanek A; Goetz R; Agyare E
    Sabouraudia; 1980 Jun; 18(2):97-104. PubMed ID: 7423334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro.
    Nenoff P; Haustein UF; Brandt W
    Skin Pharmacol; 1996; 9(6):388-94. PubMed ID: 9055360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
    Guinet R; Mazoyer MA
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification and susceptibility of clinically isolated yeast-like fungi].
    Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K
    Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.
    Brandsberg JW; French ME
    Antimicrob Agents Chemother; 1972 Nov; 2(5):402-4. PubMed ID: 4670509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of some human pathogenic yeasts and systemic fungi to myxin.
    Sekhon AS; Hargesheimer E
    J Clin Pathol; 1975 Jul; 28(7):547-9. PubMed ID: 1171116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of Candida albicans from patients with chronic oral candidiasis.
    Holbrook WP; Kippax R
    Postgrad Med J; 1979 Sep; 55(647):692-4. PubMed ID: 392486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
    Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
    Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.